Sensyne Health PLC Results of General Meeting (8579N)

TIDMSENS

RNS Number : 8579N

Sensyne Health PLC

06 June 2022

Sensyne Health plc

("Sensyne" or the "Company")

Results of General Meeting

Oxford, U.K. 6 June 2022: Sensyne Health plc (LSE:SENS) today announces that at the General Meeting held earlier today all resolutions proposed were duly passed by shareholders.

The full text of the resolutions is set out in the Notice of General Meeting in Part IV of the Circular which was sent to shareholders on 18 May 2022 (the "Circular") and is available from the Company's website at https://www.sensynehealth.com/investors/shareholder-information .

Terms used in this announcement shall be as defined in the Circular unless the context requires otherwise.

Voting on the resolutions was conducted by way of a poll and a summary of the votes received is as follows:

 
 R es No.*                    V otes       %        V otes      %       V otes        % of    Votes 
                               For                   Against             Total         ISC     Withheld*** 
 1. Approval 
  of the Sub-division 
  of the Ordinary 
  Shares                      94,932,989   94.99%   5,002,018   5.01%   99,935,007    60.12    3,060,310 
                             -----------  -------  ----------  ------  ------------  ------  ------------- 
 2. Amend the 
  Articles to 
  include the 
  rights of Deferred 
  Shares                      94,832,989   94.99%   5,002,018   5.01%   99,835,007    60.06    3,160,310 
                             -----------  -------  ----------  ------  ------------  ------  ------------- 
 3. Authority 
  to convert 
  Loan Notes 
  into Ordinary 
  Shares                      94,832,989   94.99%   5,002,018   5.01%   99,835,007    60.06    3,160,310 
                             -----------  -------  ----------  ------  ------------  ------  ------------- 
 4. Disapplication 
  of pre-emption 
  rights in respect 
  of conversion 
  of Loan Notes 
  into Ordinary 
  Shares                      94,832,989   94.99%   5,002,018   5.01%   99,835,007    60.06    3,160,310 
                             -----------  -------  ----------  ------  ------------  ------  ------------- 
 5. Authority 
  to issue Warrants 
  to subscribe 
  for Ordinary 
  Shares                      94,932,989   94.99%   5,002,018   5.01%   99,935,007    60.12    3,060,310 
                             -----------  -------  ----------  ------  ------------  ------  ------------- 
 6. Disapplication 
  of pre-emption 
  rights in respect 
  of the issue 
  of the Warrants             94,932,989   94.99%   5,002,018   5.01%   99,935,007    60.12    3,060,310 
                             -----------  -------  ----------  ------  ------------  ------  ------------- 
 7. Approve 
  the waiver 
  granted by 
  the Takeover 
  Panel of the 
  obligation 
  under Rule 
  9 of the Takeover 
  Code**                      63,035,642   96.20%   2,487,708   3.80%   65,523,350    39.42    3,118,462 
                             -----------  -------  ----------  ------  ------------  ------  ------------- 
 8. Cancellation 
  of the admission 
  to trading 
  on AIM per 
  Rule 41 of 
  the AIM Rules               95,131,382   92.47%   7,746,581   7.53%   102,877,963   61.89     117,354 
                             -----------  -------  ----------  ------  ------------  ------  ------------- 
 9. Approval 
  of the Re-registration 
  of the Company 
  as a private 
  company                     94,975,899   95.09%   4,899,654   4.91%   99,875,553    60.08    3,119,764 
                             -----------  -------  ----------  ------  ------------  ------  ------------- 
 10. Adopt the 
  New Articles 
  upon the Re-registration    94,975,899   95.09%   4,899,654   4.91%   99,875,553    60.08    3,119,764 
                             -----------  -------  ----------  ------  ------------  ------  ------------- 
 

* Resolutions numbered 1, 3, 5 and 7 were proposed and passed as ordinary resolutions and resolutions numbered 2, 4, 6, 8, 9 and 10 were proposed and passed as special resolutions.

** In accordance with the Takeover Code, the Rule 9 Waiver Resolution (resolution 7) was taken on a poll of Independent Shareholders.

***A vote withheld is not a vote in law and means the percentage of votes cast for and against excludes withheld votes.

As at 31 May 2022, the Company's issued share capital comprised of 166,464,335 Ordinary Shares, with each such Ordinary Share carrying the right to one vote. The total voting rights of the Company on the day on which shareholders had to be on the register of members in order to be eligible to vote at the General Meeting was 166,464,335 .

Expected timetable for Delisting and Re-registration

The Company confirms that, as at today's date, the expected timetable for the cancellation of the admission to trading on AIM of the Company's Ordinary Shares is as follows:

 
 Event*                                                      Date** 
 Last day of dealings on AIM in the Ordinary           17 June 2022 
  Shares 
 Cancellation of the admission to trading      7.00 a.m. on 20 June 
  on AIM of the Ordinary Shares                                2022 
 Re-registration as a private limited           On or around 4 July 
  company                                                      2022 
 

* Each of the times and dates set out in the above timetable are subject to change by the Company, in which event details of the new times and dates will be notified to London Stock Exchange plc and the Company will make an appropriate announcement to a Regulatory Information Service.

** References to times are to London time.

-ENDS-

Contact details:

 
  Sensyne Health 
  Alex Snow, Chief Executive Officer 
   Richard Pye, Chief Financial Officer             [phone] 
  Peel Hunt LLP (Nominated Adviser and Broker)      [phone] 
  Dr Christopher Golden 
   James Steel 
  Consilium Strategic Communications 
  Mary-Jane Elliott                                [phone] 
   Jessica Hodgson 
   [e-mail] 
 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ROMFQLFBLQLZBBL

(END) Dow Jones Newswires

June 06, 2022 07:46 ET (11:46 GMT)